Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free anesthesia vs conventional opioid anesthesia in breast cancer surgery after neoadjuvant chemotherapy
ChiCTR2400091285Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine, dexmedetomidine, lidocaine and ropivacaine in breast cancer (4 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoints: Cortisol level, Adrenocorticotropic hormone (ACTH) level and 2 more. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
esketaminedexmedetomidinelidocaineropivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2400091285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091285.